Table 3.
Baseline and followup values for plasma cystatin C and creatinine
| Usual Care Group | NaCl Group | Group | P Value | |
|---|---|---|---|---|
| Plasma cystatin C, mg/dl | ||||
| Year 0 | 1.04 (0.09) | 1.04 (0.09) | 1.05 (0.10) | 0.90* |
| Year 10 | 1.33 (0.11) | 1.34 (0.11) | 1.24 (0.10) | <0.02* |
| P value† | <0.01 | <0.01 | <0.01 | |
| Plasma creatinine, mg/dl | ||||
| Year 0 | 0.95 (0.08) | 0.96 (0.08) | 0.97 (0.07) | 0.95* |
| Year 10 | 1.23 (0.08) | 1.24 (0.08) | 1.14 (0.07) | <0.01* |
| P value† | <0.01 | <0.01 | <0.01 |
Values are means (SD); n = 40 participants/group. Patients with chronic kidney disease stage 2 were divided into the following three groups: usual care or treatment with oral NaCl or NaHCO3 (). P values at the end of the rows compare values in that row.
Kruskal-Wallis test for comparing three groups. All other P values were from one-way ANOVA.
P values below year 0 and year 10 values compare values for those years.